2023
DOI: 10.1016/j.mayocp.2022.10.028
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway Variants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…A total of 30 genes previously related to the leptin-melanocortin pathway were sequenced by Sema4 Laboratories (Stamford, Connecticut) and have been detailed elsewhere. [8][9][10] The study was approved by the institutional review board of Mayo Clinic (18-010159). All participants provided prior written authorization for research use of their medical records and biologic samples, including use for genotyping studies.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A total of 30 genes previously related to the leptin-melanocortin pathway were sequenced by Sema4 Laboratories (Stamford, Connecticut) and have been detailed elsewhere. [8][9][10] The study was approved by the institutional review board of Mayo Clinic (18-010159). All participants provided prior written authorization for research use of their medical records and biologic samples, including use for genotyping studies.…”
Section: Methodsmentioning
confidence: 99%
“…A total of 30 genes previously related to the leptin‐melanocortin pathway were sequenced by Sema4 Laboratories (Stamford, Connecticut) and have been detailed elsewhere 8–10 . The study was approved by the institutional review board of Mayo Clinic (18–010159).…”
Section: Methodsmentioning
confidence: 99%